23 Jun 2009 12:02
23 June 2009
IMMUNODIAGNOSTIC SYSTEMS HOLDINGS PLC
("IDS" or '"the Company")
Issue of Share Options
The Board of IDS, a leading producer of diagnostic testing kits, announces that on 22 June 2009, the following options to subscribe for ordinary shares of 2p each in the capital of the Company ("Ordinary Shares") were granted to:
| Employee | Exercise Price | Number of Shares |
| Roger Duggan | 236.5p | 66,383 |
| Paul Hailes | 236.5p | 66,383 |
| Ian Cookson | 236.5p | 66,383 |
| Anthony Wilks | 236.5p | 66,554 |
| Martha Garrity | 236.5p | 67,623 |
| Alain Rousseau | 236.5p | 66,554 |
| Ken Gibbs | 236.5p | 11,554 |
| Edward Coombes | 236.5p | 11,554 |
| Rudolf Schemer | 236.5p | 11,554 |
| Dagmaar Kasper | 236.5p | 11,554 |
The options were granted under the Company's Unapproved Share Option Scheme. The exercise of options granted is subject to the achievement of certain performance conditions set by the Board and the options are exercisable over a period of three to ten years.
Contacts:
| Immunodiagnostic Systems Holdings Plc | Tel: 0191 519 0660 |
| Roger Duggan, CEO | |
| Paul Hailes, Finance Director | |
| Brewin Dolphin Investment Banking | Tel: 0845 213 4730 |
| Andrew Emmott Sean Wyndham-Quin | |
| Walbrook PR Ltd | Tel: 020 7933 8787 |
| Paul McManus |